Related Experiment Videos
Novel polyisobutylene/polydimethylsiloxane bicomponent networks: III. Tissue compatibility
M A Sherman1, J P Kennedy, D L Ely
1Department of Polymer Science, The University of Akron, OH 44325, USA.
Journal of Biomaterials Science. Polymer Edition
|April 3, 1999
Summary
New rubbery polyisobutylene (PIB)/polydimethylsiloxane (PDMS) bicomponent networks show excellent biocompatibility. These novel materials elicited minimal tissue and cellular response in vivo, suggesting suitability for implant applications.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Tissue Engineering
Background:
- Biocompatibility is crucial for medical implants.
- Polyisobutylene (PIB) and polydimethylsiloxane (PDMS) are known for their unique properties.
- Developing novel bicomponent networks requires thorough biocompatibility assessment.
Purpose of the Study:
- To evaluate the in vivo tissue biocompatibility of novel PIB/PDMS bicomponent networks.
- To compare the biocompatibility of these networks against a standard polyethylene control.
- To determine the optimal composition for minimal host response.
Main Methods:
- In vivo implantation of PIB/PDMS bicomponent networks (70/30, 50/50, 35/65 wt%) and polyethylene into rat peritoneum.
- Histological evaluation of explants and surrounding tissues after eight weeks.
- Quantitative scoring of collagen thickness, fibrous tissue orientation, lymphocyte infiltration, and angiogenesis.
Main Results:
- PIB/PDMS bicomponent networks demonstrated comparable or reduced tissue and cellular responses versus polyethylene.
- All tested PIB/PDMS compositions showed favorable biocompatibility profiles.
- Weighted scoring indicated minimal inflammatory and fibrotic reactions for the PIB/PDMS implants.
Conclusions:
- Novel PIB/PDMS bicomponent networks exhibit promising tissue biocompatibility.
- These materials are suitable candidates for various medical implant applications.
- Further investigation into specific applications is warranted based on these findings.